MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    In vivo mapping of nigro-striatal dopamine transporter (DAT) availability in early Parkinson´s disease patients using [18F]FE-PE2I and high-resolution positron emission tomography.

    P. Fazio, P. Svenningsson, Z. Cselenyi, C. Halldin, L. Farde, A. Varrone (Stockholm, Sweden)

    Objective: The objective of the present work was to evaluate in vivo with high resolution positron emission tomography (PET), the relative loss of the dopamine…
  • 2017 International Congress

    Non-motor symptoms in Parkinson’s disease and putamen dopamine transporter uptake (DaTscan) uptake: a survey of 85 patients

    M. Qamar, A. Sauerbier, A. Rizos, K. Chaudhuri (London, United Kingdom)

    Objective: We addressed association between 30 non-motor symptoms (NMS) (using the validated Parkinson’s disease (PD) NMS Scale (NMSS)), and DaTscan putamen uptake ratios as part…
  • 2017 International Congress

    Clinical characteristics of scan without evidence of dopaminergic deficits (SWEDDs) in Japan.

    M. Takahashi, Y. Tashiro, N. Ito, T. Sato, T. Sekiguchi, A. Inaba, S. Orimo (Tokyo, Japan)

    Objective: To examine the clinical characteristics of SWEDDs and to compare to that of Parkinson’s disease (PD). Background: Patients with SWEDDs are defined as clinically…
  • 2017 International Congress

    Brain PET metabolic substrate of Impulse Control Disorders in Parkinson’s Disease

    E. Robin, A. Verger, F. Fluchere, T. Witjas, J.P. Azulay, E. Guedj, A. Eusebio (Marseille, France)

    Objective: The aim of this study was to describe the cerebral metabolic PET substrate and related connectivity changes in Parkinson's disease patients with impulse control…
  • 2017 International Congress

    Longitudinal Cortical Thickness Changes in GBA-Positive Relative to GBA-negative Parkinson’s Disease Patients with Hemiparkinsonism

    I. Stankovic, N. Kresojevic, F. Agosta, V. Markovic, E. Sarasso, P. Valsasina, I. Petrovic, M. Filippi, V. Kostic (Belgrade, Serbia)

    Objective: This study investigated the longitudinal changes of the cortical grey matter in Parkinson’s disease (PD) patients with hemiparkinsonism, with (GBA-positive) and without (GBA-negative) glucocerebrosidase…
  • 2017 International Congress

    Cognitive changes and cortical thinning evolution of parkinson’s disease patients: 4-year-follow up.

    A. Campabadal, C. Uribe, B. Segura, H. Baggio, A. Abos, A. Garcia-Diaz, M.-J. Marti, Y. Compta, F. Valldeoriola, C. Junque (Barcelona, Spain)

    Objective: The aim of the study was to investigate differences in the progression of cognitive decline and cortical thinning evolution in Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Signal intensity of cerebral gyri in corticobasal degeneration on phase difference enhanced MR images: Comparison with progressive supranuclear palsy and Parkinson’s disease

    M. Miyata, S. Kakeda, T. Yoneda, S. Ide, K. Watanabe, J. Moriya, H. Narimatsu, T. Sato, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We evaluated the signal intensity of the cerebral gyri (CG) on phase difference enhanced imaging (PADRE) for the patients with corticobasal degeneration (CBD), progressive…
  • 2017 International Congress

    EEG Shows Subclinical Motor Preparation Deficits in Parkinson’s Disease Patients with Freezing of Gait During Locomotion

    C. Fearon, J. Butler, S. Waechter, I. Killane, L. Newman, T. Munteanu, D. Birsanu, B. Magennis, R. Reilly, T. Lynch (Dublin 7, Ireland)

    Objective: Investigate motor preparation and cognition in Parkinson’s disease (PD) patients with and without freezing of gait (FOG) while sitting and stepping with EEG. Background:…
  • 2017 International Congress

    Connectivity patterns in frontal cognitive regions in Parkinson’s disease

    A. Hanganu, A. Nagano-Saito, A. Tam, N. Auclair-Ouellet, S. Jobert, B. Mejia-Constain, D. Schoemaker, C. Degroot, A.-L. Lafontaine, H. Chertkow, P. Bellec, O. Monchi (Calgary, AB, Canada)

    Objective: Evaluate the changes in brain connectivity between Parkinson’s disease (PD) with and without mild cognitive impairment (MCI). Background: Up to 40% of PD patients…
  • 2017 International Congress

    Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson’s disease

    M. Gilat, P. Bell, K. Ehgoetz Martens, M. Georgiades, J. Hall, C. Walton, S. Lewis, J. Shine (Sydney, Australia)

    Objective: Investigating the role of dopaminergic medication on the neural mechanisms underlying lower limb motor automaticity during fMRI in 23 patients with PD that were…
  • « Previous Page
  • 1
  • …
  • 1727
  • 1728
  • 1729
  • 1730
  • 1731
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley